As a part of routine stability inspections, a limited number of vials were observed to contain small, flake-like glass particles . With patient safety as our top priority, a voluntary recall is being initiated for all distributed lots of HYLENEX. This action is being taken as a precautionary measure. To date, no medical events or customer complaints associated with this issue have been reported.
Please take the following actions immediately regarding the affected product.
1. Examine your inventory to determine if you have any product. If so, remove the affected product from inventory and contact the Baxter Pharmaceuticals and Technologies Customer Service at 1-800-667-0959 to arrange for the product return.
2. Please complete the attached reply form confirming your receipt of this letter and fax it to Baxter at the number provided on the form. We are required by the FDA to obtain responses from our customers on notifications of this nature. Returning the form promptly will prevent you from receiving a repeat notice.
We appreciate your immediate attention and cooperation. 
